Furthermore, the effects of the IGF-I/IGF-IR pathway on host immunity, tissue remodeling, and inflammatory regulation suggests its possible involvement in autoimmune diseases in addition to TAO. This evidence concerns the gene IGF1 and autoimmune disease.